BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31786334)

  • 1. Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.
    Zhang G; Cao Z; Wang P; Zhu L; Zhang L; Zho Z; Shi L; Wang X
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101605. PubMed ID: 31786334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
    Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of ALA-PDT as a reliable therapy for AK in clinical practice.
    Chen J; Yuan F; Zheng L; Wen L; Gao M; Zhou W; Fan X
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103797. PubMed ID: 37775041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
    Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis.
    Li L; Li Y; Dong H; Yan J; Zhang Y; Zhang C; Xu X
    Photodiagnosis Photodyn Ther; 2024 Jun; 47():104100. PubMed ID: 38663488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
    Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term improvement on photoaging after ALA photodynamic therapy for actinic keratosis: A retrospective study.
    Zhang L; Zhao Z; Wang P; Zhang G; Wang B; Shi L; Liu X; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102181. PubMed ID: 33429100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study.
    Ulrich M; Reinhold U; Dominicus R; Aschoff R; Szeimies RM; Dirschka T
    J Am Acad Dermatol; 2021 Dec; 85(6):1510-1519. PubMed ID: 33744350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with the use of superluminescent diodes (sLED) in the treatment of actinic keratosis.
    Bartosińska J; Wolska-Gawron K; Gerkowicz A; Niewiedzioł M; Michalska-Jakubus M; Komza M; Klepaczewski T; Kwaśny M; Krasowska D
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():187-190. PubMed ID: 29684690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split-face control study.
    Li J; Zhang Y; Zhang G; Zhang L; Zhou Z; Wang P; Wang X
    Lasers Surg Med; 2023 Dec; 55(10):871-879. PubMed ID: 37814511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
    Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
    Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of laser-assisted ALA-PDT for squamous cell carcinoma in situ and field-directed ALA-PDT for actinic keratosis.
    Shen S; Liu X; Yang X; Hu C; Wang P; Wang X
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102638. PubMed ID: 34818597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients.
    Cai H; Wang YX; Sun P; Yang ZY; Tian R; Liu XY; Li Q; Qiao L; Liu W
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):260-5. PubMed ID: 23993852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
    Pei S; Kaminska ECN; Tsoukas MM
    Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.